Wyndham Hotels & Resorts (WH) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
25 Jul, 2026Executive summary
Achieved strong Q2 2026 results with 17% net income growth and 9% adjusted EBITDA growth year-over-year, driven by system expansion, higher ancillary revenues, and U.S. RevPAR growth.
System-wide rooms grew 4% year-over-year (excluding Revo), with a record development pipeline of 261,000 rooms, up 4% year-over-year.
U.S. RevPAR grew 2% year-over-year, outperforming expectations, while international RevPAR declined 6% due to EMEA, Latin America, and China softness.
Returned $86 million to shareholders in Q2 via $54 million in share repurchases and $32 million in dividends.
Net revenues declined 6% year-over-year, primarily due to lower franchise fees, Revo fee deferrals, and absence of prior year conference revenues.
Financial highlights
Q2 2026 net revenues: $375 million (down 6% year-over-year); adjusted EBITDA: $212 million (up 9%); net income: $102 million (up 17%).
Adjusted diluted EPS was $1.48 (up 11%); diluted EPS $1.36 (up 20%).
Adjusted free cash flow was $105 million in Q2 and $169 million year-to-date.
Adjusted EBITDA margin led the industry at 37%, with a 7.5% adjusted free cash flow yield.
Net cash from operating activities was $91 million (up 30%); operating income for Q2 was $174 million (up 16%).
Outlook and guidance
Raised full-year 2026 outlook: rooms growth 4.0%-4.5%, global RevPAR growth 0.0%-1.0%.
Adjusted EBITDA guidance increased to $735-$745 million; adjusted diluted EPS $4.71-$4.83.
Free cash flow conversion rate expected at 55%-60%.
Majority of remaining year-over-year comparable adjusted EBITDA growth expected in Q4.
Outlook excludes potential impact from Revo insolvency until new franchise agreements are signed.
Latest events from Wyndham Hotels & Resorts
- Record room growth, resilient earnings, and strong tech investments drive a positive 2026 outlook.WH
Q4 20259 Jul 2026 - Record room growth and resilient earnings, but 2025 outlook trimmed on RevPAR softness.WH
Q1 20258 Jul 2026 - 4% net room growth, $327M revenue, and record pipeline drive raised outlook and strong cash returns.WH
Q1 20261 May 2026 - Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025